Since my last article , "Pfizer's Turnaround Story Is Stronger Than You Think," Pfizer Inc. (NYSE: PFE ) has seen its stock price rise about 6.8% despite the growing negative sentiment toward it onWith over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conservative approach sets it apart, consistently unearthing undervalued assets within the realms of ETFs, commodities, technology, and pharmaceutical companies. ...